Alcidion Group Limited
ALC.ASXHealth Care
Provider of intelligent informatics software for high performance healthcare
Market Data
$0.096
+0.0%$126.3M
33.3x
$0.003
0.00%
-0.2%
Latest Earnings
H1 FY26 Appendix 4D and Half Year Report
26 February 2026
Alcidion Group delivered strong H1 FY26 results with revenue surging 44% to $25.5M driven by new contracts including NCIC Mizaic expansion and Leidos deals. The company turned profitable with a $1.3M net profit versus $889k loss in H1 FY25, while underlying EBITDA jumped 675% to a record $4.2M reflecting effective cost control and operational leverage. Key points: Record first half underlying EBITDA of $4.2M (+675%); Strong revenue growth of 44% to $25.5M driven by major contract wins; Turnaround to $1.3M profit from $889k loss in prior period
Recent Announcements
Reconfirming FY26 Guidance and Acquisition Completion
Alcidion Group Limited (ASX:ALC) reconfirmed its FY26 guidance with revenue expected to exceed $50M and EBITDA exceeding $5.0M, and completed the acquisition of Kyra flow products from Telstra Health on 29 June 2026, adding 33 customers and strengthening its patient flow solutions position in ANZ and the UK.
H1 FY26 Appendix 4D and Half Year Report
Alcidion Group delivered strong H1 FY26 results with revenue surging 44% to $25.5M driven by new contracts including NCIC Mizaic expansion and Leidos deals. The company turned profitable with a $1.3M net profit versus $889k loss in H1 FY25, while underlying EBITDA jumped 675% to a record $4.2M reflecting effective cost control and operational leverage. Key points: Record first half underlying EBITDA of $4.2M (+675%); Strong revenue growth of 44% to $25.5M driven by major contract wins; Turnaround to $1.3M profit from $889k loss in prior period
Get real-time alerts for ALC
Receive AI-powered earnings summaries and instant notifications when Alcidion Group Limited releases results.
Register Free